GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Nortem Biogroup (XPAR:MLBIO) » Definitions » Total Equity

Nortem Biogroup (XPAR:MLBIO) Total Equity : €6.62 Mil (As of Dec. 2022)


View and export this data going back to 2023. Start your Free Trial

What is Nortem Biogroup Total Equity?

Nortem Biogroup's total equity for the quarter that ended in Dec. 2022 was €6.62 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Nortem Biogroup Total Equity Historical Data

The historical data trend for Nortem Biogroup's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nortem Biogroup Total Equity Chart

Nortem Biogroup Annual Data
Trend Dec21 Dec22
Total Equity
5.14 6.62

Nortem Biogroup Semi-Annual Data
Dec21 Dec22
Total Equity 5.14 6.62

Nortem Biogroup Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nortem Biogroup's Total Equity for the fiscal year that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=13.468-6.852
=6.62

Nortem Biogroup's Total Equity for the quarter that ended in Dec. 2022 is calculated as

Total Equity=Total Assets(Q: Dec. 2022 )-Total Liabilities(Q: Dec. 2022 )
=13.468-6.852
=6.62

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nortem Biogroup Total Equity Related Terms

Thank you for viewing the detailed overview of Nortem Biogroup's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Nortem Biogroup (XPAR:MLBIO) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Calle Alexander Humboldt 12B, Polígono Industrial Salinas de Poniente, El Puerto de Santa María, Cadiz, ESP, 11500
Nortem Chem SA is engaged in the research, development, innovation and industrialization in the field of biochemistry and biotechnology, as well as the production and sale of products based on biochemical and/or biotechnological processes. It emerged as a biotechnological company in the field of the food and chemical industry, with maximum environmental awareness, concentrating its research and product development efforts on the development of environmentally friendly alternatives from renewable sources and obtaining its own microorganisms (Aspergillus Niger and Yarrowia lipolytica) with outstanding capabilities from adaptation and selection processes, avoiding the use of genetic modification technologies.

Nortem Biogroup (XPAR:MLBIO) Headlines

No Headlines